BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, Whittaker S, Tzonev R, Handshiev S, Verslype C, Moench C, Zeuzem S, Sauerbruch T, Guarner C, Schott E, Johnson N, Petrov A, Katzarov K, Nevens F, Zapater P, Such J. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol 2013;58:922-7. [PMID: 23318604 DOI: 10.1016/j.jhep.2012.12.020] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 10.4] [Reference Citation Analysis]
Number Citing Articles
1 Vidal González D, Pérez López KP, Vera Nungaray SA, Moreno Madrigal LG. Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers. Gastroenterología y Hepatología (English Edition) 2022;45:715-723. [DOI: 10.1016/j.gastre.2022.02.003] [Reference Citation Analysis]
2 Nunes M, Ricardo S. Chemoresistance in Ovarian Cancer: The Role of Malignant Ascites. Ovarian Cancer 2022. [DOI: 10.36255/exon-publications-ovarian-cancer-malignant-ascites] [Reference Citation Analysis]
3 Weil-Verhoeven D, Di Martino V, Stirnimann G, Cervoni JP, Nguyen-Khac E, Thévenot T. Alfapump® implantable device in management of refractory ascites: An update. World J Hepatol 2022; 14(7): 1344-1356 [DOI: 10.4254/wjh.v14.i7.1344] [Reference Citation Analysis]
4 Ignatenko GA, Kugler TE, Taradin GG, Rakitskaya IV, Kaluga AA. Efficacy and Safety of Ascites Treatment in Liver Cirrhosis. Bezopasnost' i risk farmakoterapii 2022;10:161-175. [DOI: 10.30895/2312-7821-2022-10-2-161-175] [Reference Citation Analysis]
5 Will V, Rodrigues SG, Berzigotti A. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis. Dig Liver Dis 2022:S1590-8658(21)00894-X. [PMID: 35016859 DOI: 10.1016/j.dld.2021.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zaccherini G, Tufoni M, Iannone G, Caraceni P. Management of Ascites in Patients with Cirrhosis: An Update. J Clin Med 2021;10:5226. [PMID: 34830508 DOI: 10.3390/jcm10225226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Storni F, Stirnimann J, Banz V, De Gottardi A, Stirnimann G. Treatment of refractory ascites with an automated low flow ascites pump in patients awaiting liver transplantation. Journal of Liver Transplantation 2021;4:100037. [DOI: 10.1016/j.liver.2021.100037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, Franco W, Scarcelli G, Polacheck WJ, Roque DM, Del Carmen MG, Huang HC, Demirci U, Rizvi I. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers (Basel) 2021;13:4318. [PMID: 34503128 DOI: 10.3390/cancers13174318] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
9 Italian Association for the Study of the Liver (AISF). Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2021;53:1089-104. [PMID: 34321192 DOI: 10.1016/j.dld.2021.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Çelik F, Bektaş H. Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale J Nurs 2021;29:250-62. [PMID: 34263244 DOI: 10.5152/FNJN.2021.19171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Larrue H, Vinel JP, Bureau C. Management of Severe and Refractory Ascites. Clin Liver Dis 2021;25:431-40. [PMID: 33838859 DOI: 10.1016/j.cld.2021.01.010] [Reference Citation Analysis]
12 Nguyen-khac E, Sarba R, Spahr L, Staszewicz W, Degottardi A, Storni F, Elkrief L, Dokmak S, Valla D, Pricope D, Sabbagh C, Regimbeau J. Traitement de l’ascite réfractaire par alfapump® avec cure de hernie durant la même intervention : une étude rétrospective, multicentrique, européenne chez des patients cirrhotiques. Journal de Chirurgie Viscérale 2021;158:29-39. [DOI: 10.1016/j.jchirv.2020.05.001] [Reference Citation Analysis]
13 Madoff DC, Cornman-Homonoff J, Fortune BE, Gaba RC, Lipnik AJ, Yarmohammadi H, Ray CE Jr. Management of Refractory Ascites Due to Portal Hypertension: Current Status. Radiology 2021;298:493-504. [PMID: 33497318 DOI: 10.1148/radiol.2021201960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sauerbruch T, Appenrodt B. Leberzirrhosen. Therapie-Handbuch - Gastroenterologie und Hepatologie 2021. [DOI: 10.1016/b978-3-437-23847-5.00054-5] [Reference Citation Analysis]
15 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 77] [Cited by in F6Publishing: 84] [Article Influence: 77.0] [Reference Citation Analysis]
16 Gallo A, Dedionigi C, Civitelli C, Panzeri A, Corradi C, Squizzato A. Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians. J Transl Int Med 2020;8:220-36. [PMID: 33511049 DOI: 10.2478/jtim-2020-0035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Laroumagne S, Guinde J, Berdah S, Dutau H, Capel J, Astoul P. A novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study. Respir Res 2020;21:184. [PMID: 32669106 DOI: 10.1186/s12931-020-01447-4] [Reference Citation Analysis]
18 Bendel EC, Sniderman K, Shaw C, Frederick RT, Wong F, Sanyal A, Asrani SK, Kamath PS, Capel J, Haskal ZJ. Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory Ascites. J Vasc Interv Radiol 2020;31:1256-1262.e3. [PMID: 32654961 DOI: 10.1016/j.jvir.2020.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Will V, Rodrigues SG, Stirnimann G, Gottardi A, Bosch J, Berzigotti A. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications. United European Gastroenterol J 2020;8:961-9. [PMID: 32588789 DOI: 10.1177/2050640620938525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Nguyen-Khac E, Sarba R, Spahr L, Staszewicz W, DeGottardi A, Storni F, Elkrief L, Dokmak S, Valla D, Pricope D, Sabbagh C, Regimbeau JM. Combined treatment of refractory ascites with an alfapump® plus hernia repair in the same surgical session: A retrospective, multicentre, European pilot study in cirrhotic patients. J Visc Surg 2021;158:27-37. [PMID: 32553558 DOI: 10.1016/j.jviscsurg.2020.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Alsebaey A, Rewisha E, Waked I. High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction. Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-0024-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, Asrani SK, Capel J, Kamath PS. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump. Liver Transpl 2020;26:651-61. [PMID: 31999044 DOI: 10.1002/lt.25724] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
23 Astoul P, Laroumagne S, Capel J, Maskell NA. Novel pleural-bladder pump in malignant pleural effusions: from animal model to man. Thorax 2020;75:432-4. [PMID: 32165417 DOI: 10.1136/thoraxjnl-2019-214003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Rudler M, Mallet M, Sultanik P, Bouzbib C, Thabut D. Optimal management of ascites. Liver Int 2020;40:128-35. [DOI: 10.1111/liv.14361] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
25 Dembinski J, Aranovich D, Banz V, Ehmann T, Klein I, Malago M, Richter N, Schnitzbauer AA, Staszewicz W, Tautenhahn H, Capel J, Regimbeau J. Surgical technique for placement of the automated low flow ascites pump (Alfapump). Langenbecks Arch Surg 2020;405:117-23. [DOI: 10.1007/s00423-019-01822-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Jung N, Mayet W, Mertens P, Meyer (federführend) J, Müller O, Pfeifer M, Schellinger P, Weiss N, Wendtner C. ERKRANKUNGEN DER VERDAUUNGSORGANE. Rationelle Diagnostik und Therapie in der Inneren Medizin 2020. [DOI: 10.1016/b978-3-437-06282-7.50008-5] [Reference Citation Analysis]
27 Garcia-martinez R, Diaz-ruiz R, Millan J, Bañares R. Chronic Liver Failure and Acute-on-Chronic Liver Failure. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_33] [Reference Citation Analysis]
28 Wong F. Management of Ascites. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_2] [Reference Citation Analysis]
29 Fotopoulou C, Berg T, Hausen A, Hennig R, Jalan R, Malagó M, Capel J, De Gottardi A, Stirnimann G. Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites. BMC Palliat Care 2019;18:109. [PMID: 31805921 DOI: 10.1186/s12904-019-0497-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
30 Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2018;. [PMID: 29973706 DOI: 10.1038/s41395-018-0185-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
31 Lepida A, Marot A, Trépo E, Degré D, Moreno C, Deltenre P. Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites. Aliment Pharmacol Ther 2019;50:978-87. [PMID: 31583729 DOI: 10.1111/apt.15502] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
32 Adebayo D, Neong SF, Wong F. Ascites and Hepatorenal Syndrome. Clin Liver Dis 2019;23:659-82. [PMID: 31563217 DOI: 10.1016/j.cld.2019.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
33 Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol 2019; 25(28): 3738-3752 [PMID: 31391769 DOI: 10.3748/wjg.v25.i28.3738] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
34 Macken L, Hashim A, Mason L, Verma S. Permanent indwelling peritoneal catheters for palliation of refractory ascites in end‐stage liver disease: A systematic review. Liver Int 2019;39:1594-607. [DOI: 10.1111/liv.14162] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
35 Garbin N, Doyle P, Smith B, Taylor JG, Khan MH, Khalil Q, Valdastri P. Miniature Pump for Treatment of Refractory Ascites Based on Local Magnetic Actuation. Journal of Medical Devices 2019;13:031002. [DOI: 10.1115/1.4042460] [Reference Citation Analysis]
36 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings 2019;94:714-26. [DOI: 10.1016/j.mayocp.2018.12.020] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 18.0] [Reference Citation Analysis]
37 Piano S, Tonon M, Angeli P. Ascites, Hyponatremia, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch43] [Reference Citation Analysis]
38 Garbuzenko DV. Hydrothorax in liver disease: pathogenesis, diagnosis, treatment. Klin med 2018;96:604-611. [DOI: 10.18821/0023-2149-2018-96-7-604-611] [Reference Citation Analysis]
39 Neong SF, Adebayo D, Wong F. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Expert Rev Gastroenterol Hepatol 2019;13:293-305. [PMID: 30791777 DOI: 10.1080/17474124.2018.1555469] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
40 Cerne K, Kobal B. Ascites in Advanced Ovarian Cancer. Ovarian Cancer - From Pathogenesis to Treatment 2018. [DOI: 10.5772/intechopen.72698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Solbach P, Höner zu Siederdissen C, Wellhöner F, Richter N, Heidrich B, Lenzen H, Kerstin P, Hueper K, Manns MP, Wedemeyer H, Jaeckel E. Automated low-flow ascites pump in a real-world setting: complications and outcomes. European Journal of Gastroenterology & Hepatology 2018;30:1082-9. [DOI: 10.1097/meg.0000000000001149] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
42 Storni F, Stirnimann G, Banz V, De Gottardi A. Treatment of Malignant Ascites Using an Automated Pump Device. Am J Gastroenterol 2018;113:1060-1. [PMID: 29867179 DOI: 10.1038/s41395-018-0100-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Neijenhuis M, Gevers TJG, Atwell TD, Gunneson TJ, Schimek AC, Kievit W, Drenth JPH, Kamath PS. Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites. Am J Gastroenterol 2018;113:567-75. [PMID: 29557942 DOI: 10.1038/ajg.2018.18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Deep A, Saxena R, Jose B. Acute kidney injury in children with chronic liver disease. Pediatr Nephrol 2019;34:45-59. [PMID: 29497824 DOI: 10.1007/s00467-018-3893-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
45 Solà E, Sanchez-Cabús S, Rodriguez E, Elia C, Cela R, Moreira R, Pose E, Sánchez-Delgado J, Cañete N, Morales-Ruiz M, Campos F, Balust J, Guevara M, García-Valdecasas JC, Ginès P. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites. Liver Transpl 2017;23:583-93. [PMID: 28318147 DOI: 10.1002/lt.24763] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
46 Patidar KR, Sanyal AJ. Ascites and Spontaneous Bacterial Peritonitis. Handbook of Liver Disease 2018. [DOI: 10.1016/b978-0-323-47874-8.00013-4] [Reference Citation Analysis]
47 Garcia-tsao G. Ascites and Hyponatremia. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00015-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Sauerbruch T, Appenrodt B. Leberzirrhosen. Therapie-Handbuch 2018. [DOI: 10.1016/b978-3-437-24950-1.00057-3] [Reference Citation Analysis]
49 Stirnimann G, De Gottardi A. Editorial: alfapump-an alternative to large-volume paracentesis for patients with refractory ascites? Authors' reply. Aliment Pharmacol Ther 2018;47:140-1. [PMID: 29226410 DOI: 10.1111/apt.14415] [Reference Citation Analysis]
50 Macdonald S, Jalan R. Editorial: alfapump-an alternative to large-volume paracentesis for patients with refractory ascites? Aliment Pharmacol Ther 2018;47:139-40. [DOI: 10.1111/apt.14390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
51 Zhao R, Lu J, Shi Y, Zhao H, Xu K, Sheng J. Current management of refractory ascites in patients with cirrhosis. J Int Med Res 2018;46:1138-45. [PMID: 29210304 DOI: 10.1177/0300060517735231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
52 Huelin P, Fortea JI, Crespo J, Fábrega E. Ascites: Treatment, Complications, and Prognosis. Ascites - Physiopathology, Treatment, Complications and Prognosis 2017. [DOI: 10.5772/intechopen.70384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Garbuzenko DV, Arefyev NO. Hepatic hydrothorax: An update and review of the literature. World J Hepatol 2017; 9(31): 1197-1204 [PMID: 29152039 DOI: 10.4254/wjh.v9.i31.1197] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
54 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 66] [Article Influence: 16.4] [Reference Citation Analysis]
55 Garbuzenko DV. The principles of management of patients with liver cirrhosis complicated by ascites. Klin med 2017;95:789-796. [DOI: 10.18821/0023-2149-2017-95-9-789-796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Solbach P, Höner Zu Siederdissen C, Taubert R, Ziegert S, Port K, Schneider A, Hueper K, Manns MP, Wedemeyer H, Jaeckel E. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis. Eur J Gastroenterol Hepatol 2017;29:539-46. [PMID: 28350743 DOI: 10.1097/MEG.0000000000000837] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
57 Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Stallmach A, Engelmann C, Trepte C, Capel J, De Gottardi A. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017;46:981-991. [PMID: 28940225 DOI: 10.1111/apt.14331] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
58 Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int 2018;12:122-34. [DOI: 10.1007/s12072-017-9815-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
59 Karkhanis S, Jones R, Willis A, Mccarthy E, Zia Z, Mehrzad H, O'rourke J, Holt A, Tripathi D. Radiological insertion of automated low flow ascitic pump (alfapump®) system for management of medically refractory ascites. BJR Case Rep 2017;3:20170025. [PMID: 30363221 DOI: 10.1259/bjrcr.20170025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Stirnimann G, Banz V, Storni F, De Gottardi A. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites. Therap Adv Gastroenterol. 2017;10:283-292. [PMID: 28203285 DOI: 10.1177/1756283x16684688] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
61 Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, Mathurin P, Otal P, Cabarrou P, Péron JM, Vinel JP. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology 2017;152:157-63. [PMID: 27663604 DOI: 10.1053/j.gastro.2016.09.016] [Cited by in Crossref: 227] [Cited by in F6Publishing: 238] [Article Influence: 45.4] [Reference Citation Analysis]
62 Garcia-tsao G. Ascites. Liver Pathophysiology. Elsevier; 2017. pp. 475-84. [DOI: 10.1016/b978-0-12-804274-8.00036-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Macken L, Joshi D, Messenger J, Austin M, Tibble J, Mason L, Verma S. Palliative long-term abdominal drains in refractory ascites due to end-stage liver disease: A case series. Palliat Med 2017;31:671-5. [PMID: 27707955 DOI: 10.1177/0269216316671281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Solà E, Solé C, Ginès P. Management of uninfected and infected ascites in cirrhosis. Liver Int 2016;36 Suppl 1:109-15. [PMID: 26725907 DOI: 10.1111/liv.13015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
65 Stahl JL, Levin E, Brown C, Bowling M. Hepatic Hydrothorax: Diagnosis, Clinical Implications, and Management. Clinical Pulmonary Medicine 2016;23:203-209. [DOI: 10.1097/cpm.0000000000000172] [Reference Citation Analysis]
66 La Mura V, Salerno F. Therapy of the refractory ascites: Total paracentesis vs. TIPS. Gastroenterología y Hepatología (English Edition) 2016;39:477-480. [DOI: 10.1016/j.gastre.2016.06.014] [Reference Citation Analysis]
67 La Mura V, Salerno F. Therapy of the refractory ascites: Total paracentesis vs. TIPS. Gastroenterología y Hepatología 2016;39:477-80. [DOI: 10.1016/j.gastrohep.2015.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 P LaFond J, Shah NL. Bursting with symptoms: A review of palliation of ascites in cirrhosis. Clin Liver Dis (Hoboken) 2016;8:10-2. [PMID: 31041055 DOI: 10.1002/cld.559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
69 Reinglas J, Amjadi K, Petrcich B, Momoli F, Shaw-Stiffel T. The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX (©) Catheter. Can J Gastroenterol Hepatol 2016;2016:4680543. [PMID: 27446840 DOI: 10.1155/2016/4680543] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
70 Openshaw MR, Fotopoulou C, Blagden S, Gabra H. The next steps in improving the outcomes of advanced ovarian cancer. Womens Health (Lond) 2015;11:355-67. [PMID: 26102473 DOI: 10.2217/whe.15.6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
71 Téllez L, Aicart-ramos M, Rodríguez-gandía M, Martínez J, Albillos A. Ascitis: diagnóstico diferencial y tratamiento. Medicine - Programa de Formación Médica Continuada Acreditado 2016;12:673-682. [DOI: 10.1016/j.med.2016.05.021] [Reference Citation Analysis]
72 Thiel A, Lammert F, Appenrodt B. Aszites und seine Komplikationen. Gastroenterologe 2016;11:16-20. [DOI: 10.1007/s11377-015-0033-9] [Reference Citation Analysis]
73 Day R, Hollywood C, Durrant D, Perkins P. Patient experience of non-malignant ascites and its treatment: a qualitative study. Int J Palliat Nurs 2015;21:372-9. [PMID: 26312532 DOI: 10.12968/ijpn.2015.21.8.372] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
74 Garcia-tsao G. Ascites and Its Complications. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch106] [Reference Citation Analysis]
75 Thomas MN, Sauter GH, Gerbes AL, Stangl M, Schiergens TS, Angele M, Werner J, Guba M. Automated low flow pump system for the treatment of refractory ascites: a single-center experience. Langenbecks Arch Surg. 2015;400:979-983. [PMID: 26566989 DOI: 10.1007/s00423-015-1356-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
76 Lutz P, Spengler U. Leberzirrhose — Update der Therapie. CME 2015;12:49-57. [DOI: 10.1007/s11298-015-1207-y] [Reference Citation Analysis]
77 Lenz K, Buder R, Kapun L, Voglmayr M. Treatment and management of ascites and hepatorenal syndrome: an update. Therap Adv Gastroenterol 2015;8:83-100. [PMID: 25729433 DOI: 10.1177/1756283X14564673] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
78 Dacha S, Subramanian RM. Critical Care Management in Cirrhosis. Curr Hepatology Rep 2015;14:60-68. [DOI: 10.1007/s11901-015-0255-9] [Reference Citation Analysis]
79 Stukan M, Leśniewski-kmak K, Wróblewska M, Dudziak M. Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter. Gynecologic Oncology 2015;136:466-71. [DOI: 10.1016/j.ygyno.2014.11.073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
80 Peck-Radosavljevic M, Angeli P, Cordoba J, Farges O, Valla D. Managing complications in cirrhotic patients. United European Gastroenterol J 2015;3:80-94. [PMID: 25653862 DOI: 10.1177/2050640614560452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
81 Paredes A, Sanyal AJ. Ascites and Refractory Ascites. Complications of Cirrhosis 2015. [DOI: 10.1007/978-3-319-13614-1_13] [Reference Citation Analysis]
82 Solà E, Graupera I, Ginès P. From Refractory Ascites to Dilutional Hyponatremia and Hepatorenal Syndrome: Current Options for Treatment. Curr Hepatology Rep 2014;13:189-197. [DOI: 10.1007/s11901-014-0240-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Dharel N, Sanyal AJ. Refractory Ascites: How to Establish the Diagnosis and What Can Be Done? Curr Hepatology Rep 2014;13:50-59. [DOI: 10.1007/s11901-014-0216-8] [Reference Citation Analysis]
84 Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749-1761. [PMID: 24480518 DOI: 10.1016/s0140-6736(14)60121-5] [Cited by in Crossref: 1048] [Cited by in F6Publishing: 1127] [Article Influence: 131.0] [Reference Citation Analysis]
85 Kettler B, Schrem H, Klempnauer J, Grannas G. Ascites drainage leading to intestinal adhesions at the mesentery of the small intestine with fatal outcome. Clin Med Insights Case Rep 2014;7:3-5. [PMID: 24453504 DOI: 10.4137/CCRep.S12920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Welker M, Ulrich F, Zeuzem S. Behandlung von therapierefraktärem Aszites durch Implantation eines automatisierten Pumpensystems. Gastroenterologe 2014;9:52-54. [DOI: 10.1007/s11377-013-0848-1] [Reference Citation Analysis]
87 Arroyo V. A new method for therapeutic paracentesis: the automated low flow pump system. Comments in the context of the history of paracentesis. J Hepatol 2013;58:850-2. [PMID: 23395692 DOI: 10.1016/j.jhep.2013.01.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]